These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Pharmacokinetic changes in critical illness. Boucher BA; Wood GC; Swanson JM Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999 [TBL] [Abstract][Full Text] [Related]
46. The heparins: all a nephrologist should know. Hetzel GR; Sucker C Nephrol Dial Transplant; 2005 Oct; 20(10):2036-42. PubMed ID: 16030035 [No Abstract] [Full Text] [Related]
47. Effects of renal failure on drug transport and metabolism. Sun H; Frassetto L; Benet LZ Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315 [TBL] [Abstract][Full Text] [Related]
48. [Combined cardio-renal failure: a key factor in heart failure progression and therapy]. Caramelo C; Gil P Rev Esp Cardiol; 2006 Feb; 59(2):87-90. PubMed ID: 16540027 [No Abstract] [Full Text] [Related]
50. The use of ACE inhibitors and ARBs in severe chronic kidney disease: point-counterpoint. Creamer LM; Ryan J CANNT J; 2008; 18(4):46-8. PubMed ID: 19175194 [No Abstract] [Full Text] [Related]
51. A primer on pharmacokinetics. Quan DJ Nephrol Nurs J; 2008; 35(2):213-5. PubMed ID: 18472692 [TBL] [Abstract][Full Text] [Related]
52. [The importance and value of the toxicological and biochemical results in the management of the poisoned patient]. Groszek B Przegl Lek; 2007; 64(4-5):191-3. PubMed ID: 17724863 [TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor agent in animal model and in patients with impaired renal function. Ikeda M; Furukawa H; Imamura H; Shimizu J; Ishida H; Masutani S; Tatsuta M; Kawasaki T; Satomi T Cancer Chemother Pharmacol; 2002 Jul; 50(1):25-32. PubMed ID: 12111108 [TBL] [Abstract][Full Text] [Related]
54. Acetylcysteine and fenoldopam. Promising new approaches for preventing effects of contrast nephrotoxicity. Thompson EJ; King SL Crit Care Nurse; 2003 Jun; 23(3):39-46. PubMed ID: 12830779 [TBL] [Abstract][Full Text] [Related]
57. Renal drug clearance in preterm neonates: relation to prenatal growth. Allegaert K; Anderson BJ; van den Anker JN; Vanhaesebrouck S; de Zegher F Ther Drug Monit; 2007 Jun; 29(3):284-91. PubMed ID: 17529884 [TBL] [Abstract][Full Text] [Related]
58. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring. Grill MF; Maganti R Ann Pharmacother; 2008 Dec; 42(12):1843-50. PubMed ID: 19033476 [TBL] [Abstract][Full Text] [Related]